LEMAITRE VASCULAR, INC. Marketable Securities, Unrealized Gain (Loss)
LEMAITRE VASCULAR, INC. (LMAT) reported Marketable Securities, Unrealized Gain (Loss) of $1.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2025-02-28
- LEMAITRE VASCULAR, INC. marketable securities, unrealized gain (loss) for the quarter ending 2018-09-30 was $33.00K.
- LEMAITRE VASCULAR, INC. marketable securities, unrealized gain (loss) for the quarter ending 2018-06-30 was $22.00K.
- LEMAITRE VASCULAR, INC. marketable securities, unrealized gain (loss) for the quarter ending 2018-03-31 was -$45.00K.
- LEMAITRE VASCULAR, INC. marketable securities, unrealized gain (loss) for fiscal 2024 was $1.00M, a 16.67% decline from fiscal 2023.
- LEMAITRE VASCULAR, INC. marketable securities, unrealized gain (loss) for fiscal 2023 was $1.20M, a 33.33% decline from fiscal 2022.
- LEMAITRE VASCULAR, INC. marketable securities, unrealized gain (loss) for fiscal 2022 was $1.80M.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 6 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2024-12-31 | $1.00M 10-K · filed 2025-02-28 | |||
| 2023-12-31 | $1.20M 10-K · filed 2025-02-28 | |||
| 2022-12-31 | $1.80M 10-K · filed 2024-02-29 | |||
| 2018-09-30 | $33.00K 10-Q · filed 2018-11-02 | $55.00K derived: sum of 2 quarters · filed 2018-11-02 | $11.00K 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $22.00K 10-Q · filed 2018-08-06 | -$23.00K 10-Q · filed 2018-08-06 | ||
| 2018-03-31 | -$45.00K 10-Q · filed 2018-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |